Fanconi Anemia (FA) is a rare, inherited disease which prevents bone marrow from making enough new blood cells to carry on with routine functions of the body, and it can cause defective cells which may lead to bone marrow failure, leukemia, and/or solid tumors.
Many individuals living with FA will receive a bone marrow transplant (BMT) as part of their treatment plan. For more information on the BMT process visit the University of Minnesota's BMT website
Fanconi Anemia Research Fund (FARF) is the leader in providing support and services to advance the treatment and quality of life of individuals living with Fanconi Anemia. For more information on FARF, visit their website.